573P M9140, an anti-CEACAM5 antibody drug conjugate (ADC), in patients with metastatic colorectal cancer (mCRC): Updated results from a phase I trial

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 35; p. S466
Main Authors Boni, V., Kopetz, S., Kato, K., Raghav, K., Vieito, M., Pallis, A.G., Habermehl, C., Rivera, I.I. Rodriguez
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.09.2024
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2024.08.642